1-3 of 3
Raymond Siu Ming Wong
Close
Sort by
Journal Articles

C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma

Clinical Trials & Observations
Coty Hing Yau Cheung, Chi Keung Cheng, Kam Tong Leung, Chi Zhang, Chi Yan Ho, Xi Luo, Angel Yuet Fong Kam, Tian Xia, Thomas Shek Kong Wan, Herbert Augustus Pitts, Natalie Pui Ha Chan, Joyce Sin Cheung, Raymond Siu Ming Wong, Xiao-Bing Zhang, Margaret Heung Ling Ng
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2217–2234.
https://doi.org/10.1182/bloodadvances.2023010218
Published: 2024
Includes: Supplemental data
Journal Articles

Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE

Raymond Siu Ming Wong, İrfan Yavaşoğlu, Mohamed A. Yassin, Pınar Tarkun, Sung-Soo Yoon, Xie Wei, Ashraf Elghandour, Pantep Angchaisuksiri, Mehmet Ozcan, Renchi Yang, Mervat Mattar, Masiur Rahman, Sara Ingles, Michael Goldbrunner, Jennifer A. Frueh, Jun Ho Jang
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4773–4781.
https://doi.org/10.1182/bloodadvances.2022008287
Published: 2023
Includes: Supplemental data
Journal Articles

Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria

Clinical Trials & Observations
Raymond Siu Ming Wong, Juan Ramon Navarro-Cabrera, Narcisa Sonia Comia, Yeow Tee Goh, Henry Idrobo, Daolada Kongkabpan, David Gómez-Almaguer, Mohammed Al-Adhami, Temitayo Ajayi, Paulo Alvarenga, Jessica Savage, Pascal Deschatelets, Cedric Francois, Federico Grossi, Teresita Dumagay
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2468–2478.
https://doi.org/10.1182/bloodadvances.2022009129
Published: 2023
Includes: Supplemental data